External Counterpulsation System Manufacturer
Location Texas,United States
Asking Price Range $1.0M - $2.5M
Gross Revenues $5000
Net Profit / Cash Flow $5000
Cash Flow Type Sellers Discretionary Cash
Seller Finance Not Disclosed
Year Established 1998
Number of Employees 1 - 3
Relocatable Yes
Number of Employees 1 - 3
Real Estate Leased
Training Yes, for one year.
Reason for Sale Retirement.
Description US-ECP, Inc. designed, developed and received FDA approval to market external counterpulsation (ECP) device Model US-ECP. A non-invasive, non-pharmacological, low risk painless outpatient therapy that is FDA approved, Medicare approved and insurance approved, treatment for coronary artery disease, angina, and congestive heart failure
Asking price: $2,000,000.
Contact for more information on this Medical business for sale.
Web site usecp.com
Click Here To Contact Seller
For more opportunities like this go to:
|
|
NEWSLETTER
|
|
Sign up for Free Industry-Related News on Business and Franchise Opportunities
|
|